A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design.
Curtin F, Porchet H, Glanzman R, Schneble H M, Vidal V, Audoli-Inthavong M-L, Lambert E, Hartung H P
